AURO VACCINES LLC

EAST WINDSOR, NEW JERSEY 085201401

$4.79M

Total Contract Value

16 awards

First Award

Sep 22, 2022

Last Award

Dec 1, 2025

Business Size

other than small

CAGE Code

8EWB4

Top Industries (NAICS)

NAICS Code	Obligations	Awards
541714	$4.79M	13

Contract Awards

8 awards found

75N93020C00040

Department of Health and Human Services

$7K

Sep 30, 2025

EO 14042 ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025

75N93020C00040

Department of Health and Human Services

$55K

Nov 6, 2024

EO 14042 ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025

75N93020C00040

Department of Health and Human Services

$-16,900.05

Sep 23, 2024

EO 14042 ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024

75N93020C00040

Department of Health and Human Services

$-33,783.45

May 15, 2024

EO 14042 ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024

75N93020C00040

Department of Health and Human Services

$701K

May 1, 2024

EO 14042 ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024

75N93020C00040

Department of Health and Human Services

$1.75M

Aug 31, 2023

EO 14042 ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023

75N93020C00040

Department of Health and Human Services

$2.35M

Jun 12, 2023

EO 14042 ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023

75N93020C00040

Department of Health and Human Services

$-14,594

Sep 22, 2022

EO 14042 ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2022

Business Details

UEI: JCL5JKNMYAU5
CAGE Code: 8EWB4
Address: 279 PRINCETON HIGHTSTOWN RD
EAST WINDSOR, NJ 085201401
Congressional District: NJ-03
Phone: 7328399400

Parent Company

AURO VACCINES LLC

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov